Mr Mark Chatfield
Mr

Mark Chatfield

Email: 
Phone: 
+61 7 334 65042

Background

A/Prof Mark D. Chatfield is a highly experienced statistician in the UQ Clinical Trials Centre and collaborates with researchers across the Faculty of Health, Medicine and Behavioural Sciences.

In collaboration with health and medical researchers, he has published >200 times in academic journals. He has been an investigator on 30 NHMRC/MRFF funded (>$57M) studies (mostly clinical trials). He has >20 years of experience as a biostatistician in Australia (Brisbane, Darwin, Sydney) and the UK (Cambridge, 2002-2009). He has co-supervised 8 PhD students to completion.

He plays an active role in the Australian Clinical Trials Alliance Statistics in Trials Interest Group.

Stata users around the world enjoy using his table1_mc and blandaltman commands.

He is an Honorary Fellow (Associate Professor) with Menzies School of Health Research.

Availability

Mr Mark Chatfield is:
Not available for supervision

Fields of research

Biomedical and Clinical Sciences Biostatistics Health Sciences Mathematical Sciences Statistics

Qualifications

  • Bachelor of Arts, University of Oxford
  • Masters (Coursework), University of Southampton
  • Masters (Coursework), University of Oxford

Research interests

  • Clinical trials

    Mark has been involved with a plethora of trials of various designs in a broad range of fields. He makes significant contributions to funding applications, trial design, analysis, presentation and interpretation. To date, he has published on 39 randomised trials (protocol and/or results paper). He is involved with methodological research into cluster randomised trials as well as sample size calculations.

  • Meta-analysis

    Mark has been involved with a variety of meta-analyses. He has found a novel way to interpret the heterogeneity parameter, tau, in random-effects meta-analysis of ratios. That said, he advocates for the reporting of tau, or exp(tau) for ratios, rather than tau^2 as it is most easily understood.

Search Professor Mark Chatfield’s works on UQ eSpace

304 works between 2004 and 2026
All (304) Journal Article (223) Conference Publication (80) Book Chapter (1)

301 - 304 of 304 works

2006

Book Chapter

Population levels of mild cognitive impairment in England and Wales

Fleming, Jane, Matthews, Fiona E., Chatfield, Mark and Brayne, Carol (2006). Population levels of mild cognitive impairment in England and Wales. Mild Cognitive Impairment: International Perspectives. (pp. 77-91) edited by Holly A. Tuokko and David F. Hultsch. New York, NY, United States: Taylor and Francis. doi: 10.4324/9780203782996

Population levels of mild cognitive impairment in England and Wales

2005

Journal Article

Depression in the elderly: pathological study of raphe and locus ceruleus

Syed, A, Chatfield, M, Matthews, E, Harrison, R, Brayne, C and Esiri, MM (2005). Depression in the elderly: pathological study of raphe and locus ceruleus. Neuropathology and Applied Neurobiology, 31 (4), 405-413. doi: 10.1111/j.1365-2990.2005.00662.x

Depression in the elderly: pathological study of raphe and locus ceruleus

2005

Journal Article

A systematic literature review of attrition between waves in longitudinal studies in the elderly shows a consistent pattern of dropout between differing studies

Chatfield, MD, Brayne, CE and Matthews, FE (2005). A systematic literature review of attrition between waves in longitudinal studies in the elderly shows a consistent pattern of dropout between differing studies. Journal of Clinical Epidemiology, 58 (1), 13-19. doi: 10.1016/j.jclinepi.2004.05.006

A systematic literature review of attrition between waves in longitudinal studies in the elderly shows a consistent pattern of dropout between differing studies

2004

Journal Article

Attrition and bias in the MRC cognitive function and ageing study: an epidemiological investigation

Matthews, FE, Chatfield, M, Freeman, C, McCracken, C and Brayne, C (2004). Attrition and bias in the MRC cognitive function and ageing study: an epidemiological investigation. Bmc Public Health, 4 (1) 12. doi: 10.1186/1471-2458-4-12

Attrition and bias in the MRC cognitive function and ageing study: an epidemiological investigation

Current funding

  • 2026 - 2028
    Matching multidisciplinary management strategies to people with chronic musculoskeletal pain: the MATCH pilot and feasibility randomised clinical trial
    NHMRC MRFF Novel treatments and management strategies for chronic pain
    Open grant
  • 2026 - 2028
    Vibrotexture Insole Technology for Balance Rehabilitation in People with Multiple Sclerosis
    Multiple Sclerosis Research Australia
    Open grant
  • 2025 - 2028
    Improving Food Allergy Outcomes in Adolescents
    NHMRC Clinical Trials and Cohort Studies Grants
    Open grant
  • 2024 - 2028
    The clinical and cost effectiveness of the Action Falls rehabilitation programme compared to usual care alone to reduce falls in stroke survivors (The FISS-AUSTRALIA trial)
    NHMRC-National Institute for Health Research (NIHR) Collaborative Research Grants
    Open grant
  • 2024 - 2027
    Losing touch: Exploring the neurophysiological effects of bionic sensory insole technology for balance rehabilitation
    NHMRC IDEAS Grants
    Open grant
  • 2024 - 2027
    Co-creating virtual environments with consumers to enhance self-awareness and preparedness for home after brain injury
    NHMRC MRFF PPHR - Consumer Led Research
    Open grant
  • 2023 - 2028
    The clinical and cost-effectiveness of lumbar fusion surgery for patients with persistent, severe low back pain: FusiOn veRsus bEst coNServative Care (the FORENSIC trial)
    NHMRC-National Institute for Health Research (NIHR) Collaborative Research Grants
    Open grant
  • 2023 - 2028
    Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson's disease
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2023 - 2027
    Pharmacogenomics for better treatment of fungal infections in cancer
    MRFF Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists
    Open grant
  • 2022 - 2028
    ACTIVE KNEECAPs! tArgeted effeCTIVE treatments for adolescent KNEECAP pain
    NHMRC MRFF EPCDR - Chronic Musculoskeletal Conditions in Children and Adolescents
    Open grant
  • 2022 - 2028
    Optimising Care: Phase III Trial in women with metastatic breast cancer to improve quality of life via exercise and diet (Stream 6)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2021 - 2026
    Technology Assisted and Remotely Delivered Anxiety Psychotherapy Intervention for People living with Dementia and Their Care Partners (Tech-CBT)
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2019 - 2026
    Preventing recurrent respiratory-related hospitalisations in young Indigenous children through regular azithromycin: a multi-centre.... (NHMRC Project Grant led by Menzies School of Health Research)
    Menzies School of Health Research
    Open grant

Past funding

  • 2019 - 2024
    Improving outcomes of children and young adults with primary ciliary dyskinesia (PCD):... (MRFF RCRDUN administered by Menzies School of Health Research)
    Menzies School of Health Research
    Open grant
  • 2019
    Cluster randomised trial of Staphylococcus aureus decolonisation to prevent surgical site infections
    HCF Research Foundation
    Open grant

Availability

Mr Mark Chatfield is:
Not available for supervision

Supervision history

Current supervision

  • Doctor Philosophy

    Novel trial design in evaluation of antibiotics.

    Associate Advisor

    Other advisors: Dr Patrick Harris

Completed supervision

Enquiries

For media enquiries about Mr Mark Chatfield's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au